Research programme: cancer therapeutics - Celgene/NCI Cancer Centres
Latest Information Update: 12 Jul 2016
At a glance
- Originator Abramson Cancer Center of the University of Pennsylvania; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The Herbert Irving Comprehensive Cancer Center; The Tisch Cancer Institute
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer